Where does Valencell, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Valencell, Inc. ranks #3,517 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Valencell, Inc. hold?

Valencell, Inc. holds 105 US utility patents granted between 2015 and 2024, spanning 19 technology areas.

What is Valencell, Inc.'s Innovation Score?

Valencell, Inc. has an Innovation Score of 45.9 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Valencell, Inc. focus on?

Valencell, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 101 patents, ranking #179 of 7,127 assignees active in that subclass. Grants appear in 19 CPC subclasses total.

Is Valencell, Inc.'s patent grant rate increasing or decreasing?

Valencell, Inc.'s recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Valencell, Inc.'s patents?

Valencell, Inc.'s patents average 18.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Valencell, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Valencell, Inc.

USPTO PatentsView assignee record - 105 granted patents across 19 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Valencell ranks #3,517 of 49,997 tracked US assignees by granted-patent volume, with 105 patents across 19 technology areas.

#3,517
of 49,997 US assignees by volume: Top 22%
by Innovation Score (45.9/100): 18.7
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3517 · US Corporation #3,517 · 105 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 105 grants
TOP-DECILE #3,517/49,997
PHOTO-FINISH The Translational…
CPC-FOCUS A61B · 19 areas
INNOV-PAR 45.9/100
CLAIMS-RICH 18.7 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: The Translational Genomics Research Institute (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Valencell’s 45.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 16.1 pts (35%) Velocity 3.1 pts (7%) Breadth 15.4 pts (34%) Claim depth 11.2 pts (24%)

Qualcomm Incorporated · highest

85
Nissin Kogyo · near

46
Gustav Klauke · near

46
Neturen · near

46
Valencell · this assignee

46
Vapor IO · near

46
3D Lighting… · lowest

7

What this shows Valencell's Innovation Score is 45.9/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Valencell?

Each dot is one of Valencell’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Valencell’s own 18.7 claims/patent is ABOVE the 17.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Valencell vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Valencell's grants concentrate

Valencell, Inc. is a focused PatentsView assignee: 19 CPC subclasses with 96.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (20 grants) versus a trough of 1 in 2024. By volume, Valencell sits between The Translational Genomics Research Institute and ADC Telecommunications, Inc..

Valencell's three-year grant acceleration

From 2019–2021 to 2022–2024, Valencell, Inc. moved from 51 to 24 grants (0.47x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,759. See the growth leaderboard.

The Translational…

105
Thomson Reuters G…

105
University of Mar…

105
Varex Imaging

105
Versitech

105
Xiamen Leedarson…

105
Zhejiang Orient G…

105
Valencell ◀

105
ADC Telecommunica…

104

What this shows Valencell holds 105 patents at rank #3,518, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Valencell

By rank, the assignees closest to #3,518 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Valencell's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Valencell, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Valencell ranks #179 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (46 here).

Neturen Co., Ltd. 46 Gustav Klauke GMBH 46 Vapor IO Inc. 46 Nissin Kogyo Co., Ltd. 46

Similar claim depth

Nearest assignees by average claims per patent (18.7 here).

AtriCure, Inc. 18.7 avg Enseo, LLC 18.7 avg Viacom International Inc. 18.7 avg Hartford Fire Insurance Company 18.7 avg

Valencell's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Valencell, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	9.5%
2016	6	5.7%
2017	7	6.7%
2018	7	6.7%
2019	12	11.4%
2020	20	19.0%
2021	19	18.1%
2022	20	19.0%
2023	3	2.9%
2024	1	1.0%

Which technologies does Valencell, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 101

H04R - Loudspeakers, Microphones, Gramophone Pick-ups OR Like Acoustic Electromechanical TRANSDUCERS; Deaf-aid SETS; Public Address Systems 58

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 52

Y02A - Technologies FOR Adaptation TO Climate Change 24

G02B - Optical Elements, Systems OR Apparatus 22

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 14

G10K - Sound-producing DEVICES; Methods OR Devices FOR Protecting Against, OR FOR Damping, Noise OR Other Acoustic Waves IN GENERAL; Acoustics NOT Otherwise Provided FOR 13

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 13

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

H04Q - Selecting 6

G08B - Signalling OR Calling SYSTEMS; Order TELEGRAPHS; Alarm Systems 6

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 6

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 3

A63F - Card, Board, OR Roulette GAMES; Indoor Games Using Small Moving Playing BODIES; Video GAMES; Games NOT Otherwise Provided FOR 3

Top 15 of 19 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Valencell, Inc.'s patent record in context - here's where to go next.

Valencell, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 96.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #3,517 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Valencell, Inc. against The Translational Genomics Research Institute, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.